In addition, the data obtained in our neutrophil viability screen has identified kinase targets whose inhibition significantly impacts neutrophil survival via effects on Mcl-1 and may contribute directly to neutropenia in vivo. The gene discussed is MCL1; the disease is Decreased total neutrophil count.